Alnylam Pharmaceuticals
ALNY
#378
Rank
โ‚ฌ51.98 B
Marketcap
393,48ย โ‚ฌ
Share price
-1.55%
Change (1 day)
62.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚ฌ51.98 Billion

As of December 2025 Alnylam Pharmaceuticals has a market cap of โ‚ฌ51.98 Billion. This makes Alnylam Pharmaceuticals the world's 378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ51.98 B76.24%
2024โ‚ฌ29.49 B35.74%
2023โ‚ฌ21.72 B-20.28%
2022โ‚ฌ27.25 B52.2%
2021โ‚ฌ17.90 B45.88%
2020โ‚ฌ12.27 B6.44%
2019โ‚ฌ11.53 B78.87%
2018โ‚ฌ6.44 B-38.59%
2017โ‚ฌ10.50 B243.79%
2016โ‚ฌ3.05 B-58.31%
2015โ‚ฌ7.32 B18.98%
2014โ‚ฌ6.15 B107.47%
2013โ‚ฌ2.96 B309.81%
2012โ‚ฌ0.72 B170.08%
2011โ‚ฌ0.26 B-14.57%
2010โ‚ฌ0.31 B-39%
2009โ‚ฌ0.51 B-29.77%
2008โ‚ฌ0.73 B-9.78%
2007โ‚ฌ0.81 B35.14%
2006โ‚ฌ0.60 B176.3%
2005โ‚ฌ0.21 B104.8%
2004โ‚ฌ0.10 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚ฌ51.98 Billion
by Nasdaq info icon info icon
โ‚ฌ51.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ7.29 B-85.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ65.39 B 25.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.00 B-96.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.91 B-98.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ0.48 B-99.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ217.80 B 318.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ103.84 B 99.75%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.04 B-46.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel